New pill for chronic hives enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage trial tests the safety of an experimental oral drug called EDP-978 in 98 healthy adults. Researchers will give single and multiple doses to see how the body handles it and whether it causes side effects. The drug is being developed for chronic hives, but this stu…
Phase: PHASE1 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC